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ABSTRACT
To identify genes involved in poly(A) metabolism,
we screened the yeast gene deletion collection
for growth defects in the presence of cordycepin
(3’-deoxyadenosine), a precursor to the RNA chain
terminating ATP analog cordycepin triphosphate.
Dpho80 and Dpho85 strains, which have a constitu-
tively active phosphate-response pathway, were
identified as cordycepin hypersensitive. We show
that inorganic polyphosphate (poly P) accumulated
in these strains and that poly P is a potent inhibitor
of poly(A) polymerase activity in vitro. Binding
analyses of poly P and yeast Pap1p revealed an
interaction with a kD in the low nanomolar range.
Poly P also bound mammalian poly(A) polymerase,
however, with a 10-fold higher kD compared to
yeast Pap1p. Genetic tests with double mutants of
Dpho80 and other genes involved in phosphate
homeostasis and poly P accumulation suggest that
poly P contributed to cordycepin hypersensitivity.
Synergistic inhibition of mRNA synthesis through
poly P-mediated inhibition of Pap1p and through
cordycepin-mediated RNA chain termination may
thus account for hypersensitive growth of Dpho80
and Dpho85 strains in the presence of the
chain terminator. Consistent with this, a mutation
in the 3’-end formation component rna14 was
synthetic lethal in combination with Dpho80. Based
on these observations, we suggest that binding of
poly P to poly(A) polymerase negatively regulates its
activity.
INTRODUCTION
Inorganic polyphosphate (poly P) comprises chains of 10s
to 100s of phosphate residues, connected by energy-rich
phospho-anhydride bonds. Despite the fact that poly P is
an ubiquitous molecule detected in every living cell,
our knowledge concerning its biochemistry and biological
function remains incomplete (1,2). Poly P serves impor-
tant roles as a substitute for ATP for sugar and adenylate
kinases (3,4), as phosphate reservoir with osmotic
advantage (5–8), as energy source (9) and reservoir (10),
as buﬀer against alkaline stress (11) and as chelator of
divalent ions (1).
In addition to these general functions, poly P has been
implicated in a number of regulatory processes both in
prokaryotes and eukaryotes. In Escherichia coli, poly P
is essential for survival during stationary phase (12).
It accumulates into large amounts in response to stress
situations brought about by nutritional downshift from
rich to minimal media (13), phosphate limitation (14),
amino acid depletion (15) or nitrogen starvation. During
the latter condition, poly P promotes ribosomal protein
degradation by binding and activating the Lon protease in
E. coli delivering amino acids needed to respond to
starvation (16). Poly P is also ubiquitous in mammalian
cells and tissues (17) where it has been implicated in a host
of regulatory processes. For example, the mammalian
TOR kinase, which is involved in cell growth and
proliferation (18), is activated by poly P under conditions
of nutritional starvation (19). This observation also led to
the proposal of an evolutionary conserved role for poly P
in stress response (19). Moreover, poly P was found
to enhance proliferation of human ﬁbroblast cells (20),
to stimulate calciﬁcation of osteoblast-like cells (21),
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stimulate apoptosis in human plasma and myeloma cells
(22), and more recently, poly P has been shown to have
anti-metastatic and anti-angiogenic activities (23).
Interestingly, there are several reports that link poly P
to the regulation of gene expression through eﬀects on
RNA polymerase transcription. In E. coli, poly P is
associated with RNA polymerase during the stationary
phase and inhibits speciﬁcally the transcriptional activity
of the enzymes associated with the Es
70 promoter-
recognition subunit, which is involved in the transcription
of genes during exponential growth phase (24). Moreover,
poly P induces transcription of rpoS, the stationary phase
s factor (25). Polyphosphate kinase (Ppk1), the enzyme
synthesizing poly P, is a component of the E. coli RNA
degradosome (26). Since poly P is a potent inhibitor of
the degradosome, it was suggested that Ppk1 might act to
maintain a correct microenvironment for proper mRNA
degradation (26). In addition, poly P has been shown
to associate with ribosomes and to suppress misincorpora-
tion of amino acids during translation (27).
In yeast, poly P concentrations can reach  120mM (1)
and thus poly P contributes up to 20% of the cellular
dry weight. Most of the poly P (90–99%) is localized to
the vacuole (28,29), but poly P was also detected in the
cytoplasm and the nuclei of yeast (30,33). For rat liver
nuclei, micromolar poly P concentrations were reported
(17) and for yeast nuclei a similar level of poly P is
assumed (1). Poly P content of a yeast cell is strongly
dependent on the growth phase (31,32) and the average
length of nuclear poly P polymers of approximately 45
phosphate residues was found to be changing dynamically
with growth conditions (33). Enzymes involved in
eukaryotic poly P synthesis remain mostly elusive to
this day (1), but activities indicative of an active poly P
catabolism have been associated with all cellular
compartments (31,34), including the nucleus (30,35).
The observation that a double mutant of PPN1 [encoding
a endopolyphosphatase; (36)] and PPX1 [encoding an
exopolyphosphatase; (37)] rapidly looses viability in
stationary phase (36), underscores the biological impor-
tance of poly P. We recently screened the entire collection
of haploid yeast gene deletion mutants for poly P content
(38) and found that poly P metabolism and primary
metabolism (e.g. ATP and phosphate homeostasis)
were strongly interdependent. This screen also revealed
that all cellular compartments are linked to poly P
homeostasis (38).
In this work, we establish a connection between
cellular accumulation of poly P and inhibition of
poly(A) polymerase activity. Yeast strains mutant in
central components of the phosphate response pathway
(Dpho80 and Dpho85) contained increased amounts of
poly P that contributed to cordycepin-hypersensitive
growth. We propose a role for poly P in negatively
regulating polyadenylation through inhibition of poly(A)
polymerase.
MATERIALS AND METHODS
Yeast strains and plasmids
Wild-type BY4741 (Mat a; his3D1; leu2D0; met15D0;
ura3D0) and isogenic mutant strains were obtained from
EUROSCARF. The rna14-1 genotype is Mat a; ura3-1;
trp1-1; ade2-1; leu2-3; 112; his3-11; 15; rna14-1 (39).
Double mutants were generated by disrupting the PHO80
open reading frame with a NatR cassette by homologous
recombination in Dpho4, Dpho2, Dpho84 and rna14-1
strains. PHO80 and PHO85 genes were cloned into
pRS313 using BamHI and NotI restriction sites following
PCR ampliﬁcation from genomic DNA with primers
PHO80-50 AAGATCGGATCCCTTTCTATGGAAATA
TGAATG and PHO80-30 GATCTTGCGGCCGCAAAG
AACAGTGATGATATGAAT and PHO85-50 AAGAT
CGGATCCTGTTTTAGAAATATGTGCACT and
PHO85-30 GATCTTGCGGCCGCTTTACGTTCTGCT
CTCTCACTT. Yeast strains were grown at 308C either
in YPD (1% yeast extract, 2% tryptone, 2% glucose) or in
synthetic complete medium (SD, yeast nitrogen base and
complete amino acid mixture plus 2% glucose). SD was
supplemented with cordycepin (40mg/ml) purchased from
Sigma or 50-Fluoroorotic acid (1mg/ml, Zymo Research,
Orange, CA, USA).
Poly(A) length analysis
Assays were performed essentially as described (40). In
the standard reaction, 2mg of total RNA was incubated
with 400ng recombinantly expressed yeast poly(A) poly-
merase (a gift from G. Martin, Basel) and 0.2ml[ a-
32P]-
cordycepin triphosphate (Perkin–Elmer) in reaction buﬀer
(20mM Tris–HCl pH 7.0, 50mM KCl, 0.7mM MnCl2,
10% Glycerol, 100mg/ml BSA) for 30min at 308Ci na
total volume of 12ml. After heat inactivation, RNA was
digested with RNase A and RNase T1, followed by
proteinase K treatment. Precipitated RNAs were resolved
on 15%/8.3M urea polyacrylamide gels, that were
exposed and visualized on a FLA-7000 phosphor-imager
(Fuji).
Polyadenylation assays
Conditions were as described in Refs (41) and (42) with
modiﬁcations. The yeast poly(A) polymerase reaction
mixture of 15ml contained 100ng yeast poly(A) polymer-
ase (a generous gift from G. Martin, Basel), 5pmol of
50-end labeled A15 RNA primer, 0.5mM ATP, 5mM
MgCl2, 25mM Tris–HCl pH 7.9, 20mM KCl, 10%
glycerol, 0.01mM EDTA, 0.1mg/ml BSA, 1mM DTT
and 0.02% Nonidet P-40. The reaction mixture with
bovine poly(A) polymerase consisted of 200ng bovine
poly(A) polymerase (a gift from G. Martin, Basel), 5pmol
of 50 end-labeled A15 RNA primer, 0.5mM ATP, 25mM
Tris–HCl pH 8.3, 40mM KCl, 6mM MgCl2, 0.05mM
EDTA, 0.5mM DTT, 0.01% Nonidet P-40, 10% glycerol
and 200mg/ml BSA in a total volume of 15ml. Poly P was
added to the reactions as indicated in the ﬁgure legends.
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and stopped by addition of 25mM EDTA. Reaction
products were precipitated and resolved on 15%/8.3M
urea polyacrylamide gels that were exposed and visualized
on a FLA-7000 phosphor-imager (Fuji).
Purification of recombinant E.coli polyphosphatekinase
The gene encoding the E. coli polyphosphate kinase
[EcPPK; (43)] was ampliﬁed with the primers CATGCCA
TGGGTCAGGAAAAGCTATACATCG and CGCGG
ATCCTGCGGACGAGGGGATTTATCG and cloned
with the NcoI and BamHI sites (underlined) into the
expression vector pETM41 (EMBL Protein Expression
and Puriﬁcation Unit). EcPPK was expressed as a fusion
with a maltose-binding protein in E. coli BL21 cells and
puriﬁed on amylose resin following standard protocols
(New England BioLabs, Beverly, MA, USA). The activity
was determined with the reverse reaction by measuring
ATP synthesis at 378Ci n5 0ml reactions containing 10mM
poly P88,1 mM ADP, 50mM Tris and 50mM malate,
pH 6.5 and puriﬁed EcPPK. The reactions were stopped
by heat inactivation at 908C for 2min. ATP was quantiﬁed
after the addition of 50ml luciferase reaction mixture
(ATP bioluminescence assay kit CLS II, Roche Molecular
Biochemicals) in a luminometer [Lumat LB 9507
(Berthold Technologies GmbH & Co. KG)].
Poly Pmeasurements and polyPsynthesis in vitro
Determination of poly P concentration was performed
as previously described (32). Poly P with an average chain
length of 750 residues was synthesized as described (13)
except for some modiﬁcations. Poly P was synthesized in
200ml reactions containing 138nM [g-
32P]-ATP, 1mM
ATP, 2mM creatine-phosphate, 6U creatine phosphoki-
nase(fromrabbitmuscle, Sigma-Aldrich), 150Upolyphos-
phate kinase (1 unit corresponds to the transfer of 1pmol
Pi to ADP/min), 5mM MgCl2, 50mM Tris and 50mM
malate (pH 6.5). The reactions were incubated for 16h
at 308C.
32P-labeled poly P was puriﬁed as described (33)
and was eluted in 100ml water. Radioactivity was
measured in a scintillation counter (LS1801, Beckman
Instruments, Fullerton, California) and the poly P
concentration was calculated based on the fraction of
32P that was incorporated in poly P (resulting typically in
 3mM considering phosphate residues).
Poly Pbinding
Poly P binding assays were performed as reported earlier
(16). Puriﬁed poly(A) polymerase from Saccharomyces
cerevisiae and Bos taurus was diluted to a concentration of
200nM in 100ml reaction buﬀer (50mM Tris–HCl pH 7.5,
5mM MgCl2). Equal volumes of radioactive poly P750
(0.3–30nM, 890c.p.m./pmol for yeast and 132000c.p.m./
pmol for bovine poly(A) polymerase) were added. After
5min at 378C, the mixtures were applied to nitrocellulose
ﬁlter discs (0.45mm) and washed twice with 1ml ice
cold TBS (50mM Tris–HCl pH 7.5, 100mM NaCl).
The remaining radioactivity on the ﬁlters, corresponding
to the amount of poly P–protein complex, was measured
in a scintillation counter.
RESULTS
Dpho85and Dpho80 strains arehypersensitive
towards cordycepin
Poly(A) addition by poly(A) polymerase is terminated
in vitro in the presence of cordycepin triphosphate (CoTP)
(44,45). Since temperature-sensitive mutations in the
essential 30 end formation factors Rna14p and Rna15p
render yeast cells sensitive to cordycepin (30-deoxyadeno-
sine) (46), we reasoned that a growth phenotype in
the presence of this drug may identify mutant strains
involved in poly(A) metabolism. Cordycepin is taken up
by the yeast (47) and converted into the RNA-chain
terminating CoTP, which is a substrate for RNA
synthesis. The presence of 40mg/ml cordycepin in the
medium has only mild toxic eﬀects on wild-type cells and
increased the doubling time in liquid culture by  20%
(data not shown). In contrast, a strain lacking the 30 end
formation factor Ref2p (48) showed severe growth
inhibition (Figure 1A). Thus, strains lacking non-essential
genes involved in poly(A) metabolism can be identiﬁed
through cordycepin-hypersensitive growth.
We screened a haploid S. cerevisiae gene deletion
collection (49) for growth defects in the presence of
cordycepin using a simple drop test on agar plates. The
entire results of this screening will be presented elsewhere
(S.H. and B.D., unpublished data). Here we focus on
the further characterization of cordycepin-hypersensitive
growth observed with Dpho85 and Dpho80 strains
(Figure 1A). Complementation of the mutant strains
with plasmids carrying wild-type PHO85 and PHO80
genes, respectively, demonstrated a direct requirement for
these genes for cordycepin resistance. Empty plasmids, in
contrast, did not complement. Pho85p kinase and its
cyclin partner Pho80p form a complex and are central
regulators of the PHO pathway in yeast (Figure 1B) (50).
However, Pho85p can associate with nine other cyclins to
perform functions in various cellular pathways including
the cell cycle, carbon-source utilization and glycogen
metabolism (51). We also tested mutant strains of seven
other Pho85p cyclins (Figure 1C; Dpcl1, Dpcl2, Dpcl6,
Dpcl7, Dpcl8, Dpcl9 and Dclg1). Since we could not
observe sensitivity with these strains, the cordycepin-
hypersensitive growth of Dpho85 and Dpho80 appeared to
be mainly linked to their function in phosphate home-
ostasis. The absence of Pho85p or Pho80p results in
constitutively active transcription of phosphate-dependent
genes (50). To evaluate the relation of other PHO pathway
components and the observed cordycepin sensitivity,
we analyzed strains lacking the transcription factors
Pho4p and Pho2p, the cyclin-dependent kinase inhibitor
Pho81p, the high-aﬃnity phosphate transporter Pho84p
and the target gene PHO5 (encoding a secreted acid
Nucleic Acids Research,2008, Vol. 36,No. 2 355phosphatase). None of these strains reacted to the drug
(Figure 1C and data not shown). We conclude that
a constitutively active PHO pathway underlies the
observed cordycepin hypersensitivity of Dpho85 and
Dpho80 mutants.
Dpho85and Dpho80 strains accumulate an inhibitor
ofpoly(A) polymerase
Since CoTP can act as a terminator of the poly(A)
addition reaction in vitro (44,45), we considered the
possibility that cordycepin hypersensitivity of Dpho85
and Dpho80 strains may relate to this process. Therefore,
we isolated total RNA from wild-type and mutant strains
and analyzed the length distribution of cellular poly(A).
The protocol for poly(A) labeling that we employed
included the transfer of radioactively labeled [a
32P]-CoTP
to 30-OH groups present in the RNA preparation with
recombinant yeast poly(A) polymerase (40). With wild-
type RNA, a uniformly distributed length of approxi-
mately 10–70 adenosines was observed (Figure 2A). Quite
unexpectedly, we were unable to label any poly(A) isolated
from Dpho85 and Dpho80 strains under standard
assay conditions (i.e. 1–2mg of total RNA; Figure 2A).
We considered the possibility that some inhibitory
activity may be present in the RNA preparations of the
mutant strains interfering with the activity of poly(A)
polymerase and performed the labeling assay with
decreasing amounts of total RNA. We observed that a
4- to 8-fold dilution of the total RNA from Dpho85 and
Dpho80 strains indeed allowed poly(A) labeling
(Figure 2A). Furthermore, reduced amounts of wild-type
RNA gave increased labeling eﬃciency. We conclude that
an inhibitory activity was present in the total RNA
preparations from Dpho85 and Dpho80 strains interfering
with the poly(A) labeling test and that the same inhibitor
was also present in wild-type RNA, albeit at lower
concentration.
Poly Paccumulates inDpho85 and Dpho80
strains and interferes withRNA 3’ end labeling
by poly(A) polymerase
We hypothesized that the co-puriﬁcation of a metabolite
with Dpho85 and Dpho80 RNA may cause the inhibition
of the poly(A) labeling reaction. It was suggested that
the PHO pathway is involved in regulating the synthesis
of poly P (6). However, inconsistent results were
obtained when Dpho85 and Dpho80 strains were previously
analyzed for poly P contents (6,52). Therefore, we
measured poly P levels in wild-type and mutant strains
with a recently developed assay (32) and found that
Dpho85 and Dpho80 strains had approximately 3-fold
more poly P than wild type (Figure 2B). In contrast,
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Figure 1. Dpho85 and Dpho80 strains display cordycepin-hypersensitive growth. (A) Twenty-fold serial dilutions of the indicated strains were spotted
on agar plates that either lacked (SD) or contained 40mg/ml cordycepin; plates were photographed after 72h of incubation at 308C.
Complementation of Dpho80 and Dpho85 phenotypes was tested with empty plasmid (pRS313) or with the same vector carrying the PHO80 or
PHO85 genes, respectively. (B) Schematic representation of key components of the PHO pathway (50). Pho84p is a high-aﬃnity phosphate
transporter, Pho85p and Pho80p form a cyclin-CDK (cyclin-dependent kinase) pair and Pho81p is an associated CDK inhibitor; the Pho4p
transcription factor (the target of the Pho85p/Pho80p complex) in its hypo-phosphorylated form associates with the homeodomain transcription
factor Pho2p to drive the expression of phosphate-regulated genes, like e.g. the Pho5p secreted acid phosphatase. (C) Cordycepin hypersensitivity is
restricted to PHO pathway-dependent functions of Pho85p. Drop test as in A) with mutant yeast strains lacking the indicated Pho85p cyclins (upper
panel) and components of the PHO pathway (lower panel) on medium lacking or containing 40mg/ml cordycepin.
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show this accumulation; indeed poly P concentrations
were reduced in Dpho4, Dpho2 and Dpho84 mutant strains
(Figure 5D) (6,53). These results support the idea that
poly P metabolism is regulated by the PHO pathway and
that constitutive activity of this pathway (in the absence of
Pho85p and Pho80p) resulted in increased cellular poly P
concentrations.
The accumulation of poly P in Dpho85 and Dpho80
strains prompted us to test whether poly P is an inhibitor
of poly(A) polymerase. Therefore, we repeated the
poly(A) labeling test with standard amounts of RNA
(2mg) and added either Dpho80 RNA or increasing
amounts of poly P with diﬀerent average chain length
(21, 61 and 750 phosphate residues). We observed
that both the addition of Dpho80 RNA and of poly P
resulted in inhibition of the labeling reaction (Figure 2C).
The inhibition was nearly complete with the highest
concentration of poly P employed (200nM). However,
in multiple repetitions of this experiment, we could
not observe a clear correlation of the degree of
inhibition and the chain length of poly P included in
the assay.
To demonstrate that poly P is indeed the inhibitory
activity present in the Dpho85 and Dpho80 RNA prepara-
tions, we treated the RNAs with recombinant yeast
exopolyphosphatase (Ppx1p) prior to the labeling reac-
tion. Ppx1p speciﬁcally degrades poly P and does not act
on pyrophosphate or ATP (54). Figure 2D shows that we
were able to label the poly(A) content of Dpho85 and
Dpho80 RNA preparations following Ppx1p treatment
and the observed distribution of poly(A) in the mutant
strains appeared normal. No poly(A) was detected
when reaction buﬀer replaced Ppx1p or when the Ppx1p
was heat-denatured prior to use. Interestingly,
the labeling eﬃciency of wild-type RNA following
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the labeling reaction was performed.
Nucleic Acids Research,2008, Vol. 36,No. 2 357Ppx1p pre-treatment was also enhanced, demonstrating
the presence of poly P also in wild-type RNA, consistent
with our poly P measurements in wild-type strains
(Figure 2B). Taken together the results from
this ﬁgure show that poly P accumulated in Dpho85 and
Dpho80 strains, that this metabolite co-puriﬁed with total
RNA extracted from mutant and wild-type strains and
that poly P was responsible for the observed inhibition of
poly(A) polymerase.
PolyP binds poly(A)polymerase
Since the poly(A)-labeling assay uses CoTP, poly(A)
polymerase activity is restricted to a single round of
nucleoside addition. To examine the eﬀects of poly P
under multiple turn-over conditions, we performed
poly(A) polymerase assays with an end-labeled A15
RNA primer, cold ATP and recombinant yeast Pap1p
(Figure 3A). Under the conditions employed, yeast
Pap1p extended the primer to  300 to 400 adenosines in
60min. In the presence of 2nM poly P750, we observed a
slight reduction of the length of the polyadenylation
products during the time course. This eﬀect was stronger
with 20nM poly P750 and 200nM resulted in almost
complete inhibition. Similar eﬀects were observed when
poly P of varying length (average of 28 and 61 phosphate
residues) was tested (data not shown). The poly P
concentrations used for these assays are likely to be
physiologically relevant, as yeast nuclei are thought to
harbor poly P concentrations of up to 89mM (1).
Next, we tested whether poly P also inhibited the
activity of bovine poly(A) polymerase. Under the
employed conditions bovine Pap extended the A15 RNA
primer by approximately 100 adenosines within 1 hour
(Figure 3B). When 20nM to 2mM of poly P750 were
included in the reaction, the length of the products was
reduced but inhibition was not complete. Therefore,
poly P was a less potent inhibitor of bovine poly(A)
polymerase compared to the yeast enzyme.
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A possible explanation for the inhibitory eﬀect on
poly(A) polymerase activity could be the chelation of
magnesium ions which are essential for Pap1p function.
However, the magnesium in our assays is present in
large molar excess over inhibitory poly P concentrations
(calculated as the amount of free inorganic phosphate).
Therefore, we considered the possibility that poly P
may inhibit the enzymes by direct binding. To test this,
we performed ﬁlter-binding assays with radioactively
labeled poly P750 and yeast or bovine poly(A) polymerase.
We determined an apparent dissociation constant of
0.38nM for the yeast enzyme and of 2.7nM for the
bovine enzyme (Figure 4). It has to be pointed out,
however, that one poly P molecule is likely to provide
multiple binding sites for Pap1p. Therefore, it seems
possible that binding was inﬂuenced by avidity
eﬀects. Irrespective of that, the tight binding of poly P
to poly(A) polymerase was most likely responsible for the
observed inhibitory eﬀects of poly P in polyadenylation
assays.
To address the mechanisms of inhibition, we considered
the possibility that poly P binding may result in unspeciﬁc
aggregation or precipitation of the enzyme. To test
this idea we incubated Pap1p with increasing amounts of
poly P, collected protein aggregates by centrifugation
and resolved remaining soluble material by SDS–PAGE.
As shown in Figure 3C, poly P binding did not result in
precipitation of the enzyme. Thus, unspeciﬁc aggregation
can be excluded as a possible reason for the observed
inhibition. To test whether the inhibition of poly P on
Pap1p activity was reversible, we pre-incubated Pap1p
with 200nM poly P to allow binding of poly P and Pap1p.
As expected, this resulted in strong inhibition of poly-
adenylation activity (Figure 3D, lanes 7–11). However,
Pap1p activity could be almost completely restored by
treatment of the Pap1p–poly P complexes with Ppx1p
(Figure 3D, lanes 12–16). This demonstrated that the
inhibition of Pap1p by poly P was reversible.
The Pap1p that we used in the poly(A) length analysis
and in the polyadenylation assay was puriﬁed from E. coli,
which also contains poly P (1). Thus, puriﬁed Pap1p
may already be partially bound to poly P causing a partial
inhibition of the enzymatic activity. To test this, we
performed a polyadenylation assays with Pap1p that
was pretreated with Ppx1p. Since the treatment did not
noticeably increase the activity of Pap1p preparation
(data not shown), we conclude that most of Pap1p that
we used in our experiments was not pre-bound by poly P.
This indicated that the conditions used for over-expression
of Pap1p did not induce signiﬁcant poly P accumulation in
E. coli.
PolyP accumulation contributes to cordycepin sensitivity
We showed that Dpho85 and Dpho80 strains are
cordycepin hypersensitive, that these strains accumulated
poly P and that poly P acted as an eﬃcient inhibitor
of poly(A) polymerase. These observations suggested a
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Figure 4. Binding of poly P to yeast and bovine poly(A) polymerase. Poly P binding by yeast (A) and bovine (B) poly(A) polymerase determined by
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to derive the indicated apparent kD values. The slope of the lines obtained equal  1/kD.
Nucleic Acids Research,2008, Vol. 36,No. 2 359correlation between cellular poly P accumulation and
the drug-dependent growth defect. Ogawa and co-workers
(6) reported accumulation of poly P in strains mutant for
PHM5, PHM6, PHM2 and CTF19 during the so-called
‘overplus’ conditions. However, we could not observe
cordycepin-hypersensitive growth associated with these
mutant strains (Figure 5A). Moreover, our poly P
measurements in these strains did not indicate a signiﬁcant
increase of the polymer under conditions, which revealed a
strong increase in Dpho85 and Dpho80 strains (Figure 5B).
The diﬀerences between the measurements presented here
and in Ogawa et al. are possibly due to diﬀerences in
growth conditions at the time of measurement. Further-
more, our recent genome-wide assessment of poly P
metabolism failed to identify other mutants that would
result in poly P accumulation comparable to levels
observed in Dpho85 and Dpho80 strains (38). It seems
possible, therefore, that cordycepin-hypersensitive growth
is a consequence of elevated poly P levels exceeding a
certain threshold in Dpho85 and Dpho80 strains and that
such levels are not achieved or stably maintained in other
mutants defective in poly P metabolism.
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to poly P accumulation in Dpho85 and Dpho80 mutants,
we interfered with the ability of the strains to synthesize
poly P and asked whether this alleviated cordycepin
sensitivity. When low concentrations of phosphate
(0.1mM) are present in the medium growth of the yeast
is only marginally reduced, but no signiﬁcant poly P
accumulation can be measured (32). We tested Dpho80
strains on plates containing cordycepin but low phosphate
and found that Dpho80 strains showed signiﬁcant resis-
tance to cordycepin under these conditions (Figure 5C).
This observation suggested that abundant phosphate
was required for the observed cordycepin hypersensitivity.
Furthermore, the PHO pathway regulates poly P
accumulation in yeast (6). Figure 5D shows that cellular
levels of poly P were signiﬁcantly reduced in Dpho2, Dpho4
and Dpho84 mutants compared to wild type. We produced
double mutants of Dpho80 and other components of the
PHO pathway and found that Dpho80 Dpho4, Dpho80
Dpho2 and Dpho80 Dpho84 double mutants did not
accumulate poly P (Figure 5D). The cellular poly P
content of the analyzed double mutants correlated well
with a loss of cordycepin hypersensitivity associated with
the single Dpho80 mutation (Figure 5C). These observa-
tions are consistent with the proposal that poly P
accumulation in Dpho80 strains contributed to cordycepin
hypersensitivity. Increased cellular poly P levels may
interfere with poly(A) polymerase activity, and this may
cause hypersensitive growth in the presence of cordycepin,
another inhibitor of RNA synthesis.
To further test this idea we asked whether a tempera-
ture-sensitive mutation in the 30 end formation factor
Rna14p (rna14-1) can duplicate the eﬀects observed with
cordycepin in Dpho80 mutants. It was previously shown
that combination of mutations in rna14 and pap1 resulted
in a synthetic growth defect (39) and rna14 mutant
strains are cordycepin hypersensitive [(46); our unpub-
lished data]. Figure 5E shows that combination of the
Dpho80 mutation with the rna14-1 allele indeed resulted in
synthetic lethality. This genetic interaction strongly
supported the proposal that accumulation of poly P in
Dpho80 strains aﬀected 30 end formation via inhibition of
poly(A) polymerase activity and that this inhibition in
combination with another defect in 30 end formation led to
the observed synthetic growth defect.
DISCUSSION
We provide evidence for an unexpected link between
poly P metabolism and polyadenylation in yeast. We
propose that a synergistic eﬀect of poly P-mediated
inhibition of poly(A) polymerase together with inhibition
of RNA synthesis by CoTP can cause lethality. Synthetic
lethality observed between PHO80 and an essential factor
involved in 30 end formation underscores this assumption.
Poly P may therefore play a role in the regulation of
poly(A) polymerase activity.
The starting point of this work was an unbiased
genome-wide screen for mutants that showed hypersensi-
tive and/or resistant growth in the presence of cordycepin.
The rational for this screen was that cordycepin will be
converted to CoTP, which will then provoke RNA-chain
termination in the nucleus. Although CoTP will terminate
RNA synthesis when incorporated during transcription,
it seems possible that polyadenylation would be a more
sensitive target since up to 70 consecutive adenosines are
incorporated during this process. This may be particularly
pronounced under the low cordycepin conditions
(40mg/ml) that were employed during our screening;
as expected, mutants in 30 end formation factors displayed
hypersensitive growth in the presence of such cordycepin
concentrations (Figure 1A and data not shown). Although
it remains unclear which other cellular ATP-consuming
activities are sensitive to cordycepin or CoTP, cordycepin-
hypersensitive growth can be indicative of a functional
involvement of a mutation in 30 end formation and
poly(A) metabolism. A complete account of the results
obtained from our cordycepin-dependent growth screen-
ing will be presented elsewhere (S.H. and B.D., unpub-
lished data). However, no additional links emerged
between cordycepin hypersensitivity and poly P metabo-
lism other than the one presented here for Dpho85 and
Dpho80 strains.
The kinase activity of the Pho85p/Pho80p CDK–cyclin
complex controls phosphate-dependent gene expression
by regulating both the activity and localization of the
Pho4p transcription factor (50,55). Interestingly, poly P
was proposed to act as a phosphate buﬀer that can be
mobilized to maintain constant internal phosphate levels
under conditions where external phosphate levels ﬂuc-
tuate (7,8) and the PHO pathway was linked to expression
of genes that are involved in poly P homeostasis (6). As a
consequence, constitutive activation of the PHO pathway
(e.g. in Dpho80 strains) was expected to result in increased
poly P levels. However, Ogawa and co-workers (6) could
not observe increased levels of poly P in Dpho80 strains.
In contrast, it was reported that Dpho85 strains have
increased poly P (52). We re-evaluated the poly P content
of Dpho85 and Dpho80 strains and detected an approxi-
mately 3-fold increase in both strains compared to wild-
type (Figure 2B). We attribute these conﬂicting poly P
measurements to ﬂuctuations of poly P levels in the yeast
depending on the growth state and recently proposed
a standardized procedure for poly P determination (32).
We found that the presence of increased amounts of
co-puriﬁed poly P in RNA preparations from Dpho85 and
Dpho80 strains was accompanied by a strong inhibition
of poly(A) polymerase activity. Consistent with our
observations, previous biochemical work on the eﬀects
of poly P on yeast Pap1p revealed an inhibitory activity on
tRNA primed poly(A) synthesis (56). We show in this
work by ﬁlter-binding assays that poly P directly binds to
yeast Pap1p with a kD in the low nanomolar range
(0.38nM). This value is comparable to the kD of 0.48nM
that was determined for the poly P–Lon interaction, which
stimulates Lon protease activity (16). Pap1p and Lon are
thus the interactors with the highest reported aﬃnities
for poly P. Consistent with a physiological relevant
role for the interaction of poly P and Pap1p, nuclear
poly P levels were reported to reach micromolar concen-
trations (1); furthermore, nuclei predominantly contain
Nucleic Acids Research,2008, Vol. 36,No. 2 361poly P of an average chain length of approximately
45 phosphate residues (33), and poly P with similar length
(poly P28 and poly P61) acted as eﬃcient inhibitor of
Pap1p in our in vitro experiments (Figure 2C). We have
not delineated the binding site of poly P on Pap1p, but
potential interaction surfaces include regions of RNA
primer binding or of ATP binding (57,58). Notably,
binding of poly P to bovine poly(A) polymerase
and inhibition of its activity is approximately 10-fold
weaker compared to the yeast enzyme. This may have
important consequences on a potential in vivo interaction
of poly P and poly(A) polymerases in higher eukaryotes.
What is the biological role of poly P-mediated inhibi-
tion of poly(A) polymerase activity? We predict that such
a function must be connected to growth conditions that
are accompanied by high poly P concentrations and that
the control of poly P levels is at least partially under
control of the PHO pathway. We recently showed that
poly P content reaches a peak when cells experience the
diauxic shift following depletion of glucose from the
medium (32). This growth phase is characterized by major
changes in the gene expression program (59,60). It seems
possible that the down-regulation of many hundreds of
genes during diauxic shift is accompanied by an inhibition
of polyadenylation. In this context, it is worth pointing
out that cellular poly(A) levels inversely correlate
with poly P levels when cells enter diauxic shift (32,60).
Our observation that the inhibitory eﬀects of poly P on
Pap1p were completely reversible (Figure 3D) may
indicate that poly P action can be transient and controlled
through a dynamic nuclear poly P metabolism (33).
Furthermore, ﬂuctuations of nuclear poly P levels may
interfere with RNA processing in a microenvironment as
was suggested for the regulation of the bacterial degrado-
some (26). Since no global polyadenylation defect could be
observed at steady state in Dpho80 and Dpho85 strains
(Figure 2D) poly P may act on speciﬁc gene loci and not
as a general suppressor of Pap1p activity. A deeper
understanding of poly P biochemistry and metabolism will
be required to address these possibilities in future
experiments.
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